FOLD - Amicus Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.26B
Enterprise Value 32.06B
Trailing P/E N/A
Forward P/E 1-14.42
PEG Ratio (5 yr expected) 1-0.06
Price/Sales (ttm)35.59
Price/Book (mrq)4.03
Enterprise Value/Revenue 332.37
Enterprise Value/EBITDA 6-9.96

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-331.16%

Management Effectiveness

Return on Assets (ttm)-14.92%
Return on Equity (ttm)-70.61%

Income Statement

Revenue (ttm)63.61M
Revenue Per Share (ttm)0.37
Quarterly Revenue Growth (yoy)197.70%
Gross Profit (ttm)30.69M
EBITDA -206.74M
Net Income Avi to Common (ttm)-292.62M
Diluted EPS (ttm)-1.69
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)538.95M
Total Cash Per Share (mrq)2.85
Total Debt (mrq)169.44M
Total Debt/Equity (mrq)30.16
Current Ratio (mrq)10.88
Book Value Per Share (mrq)2.97

Cash Flow Statement

Operating Cash Flow (ttm)-230.24M
Levered Free Cash Flow (ttm)-188.35M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.11
52-Week Change 3-7.39%
S&P500 52-Week Change 37.95%
52 Week High 317.62
52 Week Low 311.57
50-Day Moving Average 312.41
200-Day Moving Average 314.35

Share Statistics

Avg Vol (3 month) 32.42M
Avg Vol (10 day) 32.24M
Shares Outstanding 5189.14M
Float 156.75M
% Held by Insiders 10.67%
% Held by Institutions 1120.17%
Shares Short (Sep 28, 2018) 426.07M
Short Ratio (Sep 28, 2018) 49.39
Short % of Float (Sep 28, 2018) 413.94%
Short % of Shares Outstanding (Sep 28, 2018) 413.78%
Shares Short (prior month Aug 31, 2018) 426.32M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A